WILMINGTON, Mass., Sept. 2, 2014 /PRNewswire/ — Implant Sciences Corporation (IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold $1.2 million worth of trace detectors to a customer in the European Union. The units will be deployed for critical infrastructure protection and homeland security.
“We won this contract in a highly competitive environment. The contract win was a result of our trace detectors exceeding the customer’s expectations, particularly when compared to competitive products, as well as the service and support provided by our superior local distributor,” stated Dr. Darryl Jones, Implant Sciences’ Vice President of Global Sales and Marketing.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. Implant Sciences is only the third manufacturer, and the sole American-owned company, to currently have an ETD system named as a Qualified Product by the US Transportation Security Administration. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. It also received a GSN 2013 Homeland Security Award for “Best Explosives Detection Solution”. All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.
